Single-chain antibody-delivered Livin siRNA inhibits human malignant melanoma growth in vitro and in vivo.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hao,Wang

第一单位： 1 General Hospital of Ningxia Medical University, Yinchuan, China.;2 Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

作者： Hao,Wang ^[1] ; Yifei,Yang ^[2] ; Wei,Wang ^[3] ; Bing,Guan ^[4] ; Meng,Xun ^[5] ; Hai,Zhang ^[6] ; Ziling,Wang ^[7] ; Yong,Zhao ^[6]

作者单位： 1 General Hospital of Ningxia Medical University, Yinchuan, China.;2 Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. ^[1] 3 Department of Prevention and Healthcare, Affiliated Hospital of Hebei University of Engineering, Handan, China. ^[2] 4 Zhejiang-California International NanoSystems Institute, Hangzhou, China. ^[3] 5 Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. ^[4] 6 Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China. ^[5] 7 Laboratory Animal Center, The Fourth Military Medical University, Xi'an, China. ^[6] 8 Institute of Blood Transfusion Medicine, Academy of Military Medical Sciences, Beijing, China. ^[7]

关键词 Livin Small interfering RNA malignant melanoma single-chain antibody targeting delivery